These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23732296)

  • 1. Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies.
    Pandya AA; Yakel JL
    Biochem Pharmacol; 2013 Oct; 86(8):1054-62. PubMed ID: 23732296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors.
    Pandya A; Yakel JL
    Biochem Pharmacol; 2011 Oct; 82(8):952-8. PubMed ID: 21596025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulation of nicotinic acetylcholine receptors.
    Chatzidaki A; Millar NS
    Biochem Pharmacol; 2015 Oct; 97(4):408-417. PubMed ID: 26231943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.
    Gill-Thind JK; Dhankher P; D'Oyley JM; Sheppard TD; Millar NS
    J Biol Chem; 2015 Feb; 290(6):3552-62. PubMed ID: 25516597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desformylflustrabromine: A Novel Positive Allosteric Modulator for beta2 Subunit Containing Nicotinic Receptor Sub-Types.
    Pandya AA
    Curr Pharm Des; 2016; 22(14):2057-63. PubMed ID: 26818864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting properties of α7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors.
    Gill JK; Chatzidaki A; Ursu D; Sher E; Millar NS
    PLoS One; 2013; 8(1):e55047. PubMed ID: 23383051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
    Al Rawashdah S; Hamrouni A; Sadek B; Amer R; Metwaly M; Atatreh N; Ghattas MA
    J Mol Graph Model; 2019 Nov; 92():44-54. PubMed ID: 31306865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
    Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
    Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators.
    Wilkerson JL; Deba F; Crowley ML; Hamouda AK; McMahon LR
    Neuropharmacology; 2020 May; 168():108008. PubMed ID: 32113032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization and high-throughput screening of positive allosteric modulators of α7 nicotinic acetylcholine receptors in IMR-32 neuroblastoma cells.
    Gopalakrishnan SM; Philip BM; Gronlien JH; Malysz J; Anderson DJ; Gopalakrishnan M; Warrior U; Burns DJ
    Assay Drug Dev Technol; 2011 Dec; 9(6):635-45. PubMed ID: 21309712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
    Gill JK; Savolainen M; Young GT; Zwart R; Sher E; Millar NS
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5867-72. PubMed ID: 21436053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.
    Wang J; Lindstrom J
    Br J Pharmacol; 2018 Jun; 175(11):1805-1821. PubMed ID: 28199738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria.
    Uspenska K; Lykhmus O; Arias HR; Pons S; Maskos U; Komisarenko S; Skok M
    Int J Biochem Cell Biol; 2018 Jun; 99():226-235. PubMed ID: 29704624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain.
    Bagdas D; Ergun D; Jackson A; Toma W; Schulte MK; Damaj MI
    Eur J Pain; 2018 Jan; 22(1):84-93. PubMed ID: 28809075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors.
    Toma W; Ulker E; Alqasem M; AlSharari SD; McIntosh JM; Damaj MI
    Curr Top Behav Neurosci; 2020; 45():153-166. PubMed ID: 32468494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric Agonism of
    Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
    Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses.
    Sanders VR; Millar NS
    Pharmacol Res; 2023 May; 191():106759. PubMed ID: 37023990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain.
    Nirogi R; Goura V; Abraham R; Jayarajan P
    Eur J Pharmacol; 2013 Jul; 712(1-3):22-9. PubMed ID: 23660369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.